1856 related articles for article (PubMed ID: 33558079)
21. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.
Spila Alegiani S; Crisafulli S; Giorgi Rossi P; Mancuso P; Salvarani C; Atzeni F; Gini R; Kirchmayer U; Belleudi V; Kurotschka PK; Leoni O; Ludergnani M; Ferroni E; Baracco S; Massari M; Trifirò G;
Rheumatology (Oxford); 2021 Oct; 60(SI):SI25-SI36. PubMed ID: 33856453
[TBL] [Abstract][Full Text] [Related]
22. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
Klimke A; Hefner G; Will B; Voss U
Med Hypotheses; 2020 Sep; 142():109783. PubMed ID: 32402766
[TBL] [Abstract][Full Text] [Related]
23. Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial.
Stoll F; Blank A; Mikus G; Czock D; Foerster KI; Hermann S; Häußler K; Muhareb A; Hummler S; Weiss J; Burhenne J; Haefeli WE
Trials; 2020 Jun; 21(1):584. PubMed ID: 32600363
[TBL] [Abstract][Full Text] [Related]
24. Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists.
Bosquet A; Affo C; Plaisance L; Poenou G; Mortier E; Mahé I
PLoS One; 2022; 17(1):e0261843. PubMed ID: 35061735
[TBL] [Abstract][Full Text] [Related]
25. No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19.
Faíco-Filho KS; Conte DD; de Souza Luna LK; Carvalho JMA; Perosa AHS; Bellei N
Braz J Microbiol; 2020 Dec; 51(4):1765-1769. PubMed ID: 33111169
[TBL] [Abstract][Full Text] [Related]
26. Hydroxychloroquine in Hospitalized Patients with COVID-19: Real-World Experience Assessing Mortality.
Annie FH; Sirbu C; Frazier KR; Broce M; Lucas BD
Pharmacotherapy; 2020 Nov; 40(11):1072-1081. PubMed ID: 33044019
[TBL] [Abstract][Full Text] [Related]
27. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering.
Di Castelnuovo A; Gialluisi A; Antinori A; Berselli N; Blandi L; Bonaccio M; Bruno R; Cauda R; Costanzo S; Guaraldi G; Menicanti L; Mennuni M; My I; Parruti G; Patti G; Perlini S; Santilli F; Signorelli C; Stefanini G; Vergori A; Ageno W; Agodi A; Agostoni P; Aiello L; Al Moghazi S; Arboretti R; Aucella F; Barbieri G; Barchitta M; Bonfanti P; Cacciatore F; Caiano L; Cannata F; Carrozzi L; Cascio A; Castiglione G; Ciccullo A; Cingolani A; Cipollone F; Colomba C; Colombo C; Crisetti A; Crosta F; Danzi GB; D'Ardes D; de Gaetano Donati K; Di Gennaro F; Di Tano G; D'Offizi G; Fusco FM; Gaudiosi C; Gentile I; Gianfagna F; Giuliano G; Graziani E; Guarnieri G; Langella V; Larizza G; Leone A; Maccagni G; Magni F; Maitan S; Mancarella S; Manuele R; Mapelli M; Maragna R; Marcucci R; Maresca G; Marongiu S; Marotta C; Marra L; Mastroianni F; Mengozzi A; Meschiari M; Milic J; Minutolo F; Mussinelli R; Mussini C; Musso M; Odone A; Olivieri M; Palimodde A; Pasi E; Pesavento R; Petri F; Pivato CA; Poletti V; Ravaglia C; Righetti G; Rognoni A; Rossato M; Rossi I; Rossi M; Sabena A; Salinaro F; Sangiovanni V; Sanrocco C; Schiano Moriello N; Scorzolini L; Sgariglia R; Simeone PG; Spinicci M; Tamburrini E; Torti C; Trecarichi EM; Vettor R; Vianello A; Vinceti M; Virdis A; De Caterina R; Iacoviello L
J Healthc Eng; 2021; 2021():5556207. PubMed ID: 34336157
[TBL] [Abstract][Full Text] [Related]
28. Hydroxychloroquine in Treatment of Asymptomatic and Mildly Symptomatic COVID-19: A Multi-Centre Cohort Study.
Jain S; Sharma SK; Suri V; Yaddanapudi N; Malhotra P; Bhalla A; Singh MP; Koushal V; Kajal K; Jakulla RS; Marrapu S; Guru RR; Bora I; Chopra V; Sibia R; Puri GD
J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062802
[TBL] [Abstract][Full Text] [Related]
29. A multiscale absorption and transit model for oral delivery of hydroxychloroquine: Pharmacokinetic modeling and intestinal concentration prediction to assess toxicity and drug-induced damage in healthy subjects.
Kannan R; Przekwas A
Int J Numer Method Biomed Eng; 2020 Dec; 36(12):e3403. PubMed ID: 33029911
[TBL] [Abstract][Full Text] [Related]
30. An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.
Purwati ; Miatmoko A; Nasronudin ; Hendrianto E; Karsari D; Dinaryanti A; Ertanti N; Ihsan IS; Purnama DS; Asmarawati TP; Marfiani E; Yulistiani ; Rosyid AN; Wulaningrum PA; Setiawan HW; Siswanto I; Tri Puspaningsih NN
PLoS One; 2021; 16(6):e0252302. PubMed ID: 34143818
[TBL] [Abstract][Full Text] [Related]
31. Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea.
Bae S; Ghang B; Kim YJ; Lim JS; Yun SC; Kim YG; Lee SO; Kim SH
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672785
[TBL] [Abstract][Full Text] [Related]
32. No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
Sands K; Wenzel R; McLean L; Korwek K; Roach J; Miller K; Poland RE; Burgess LH; Jackson E; Perlin JB
Int J Infect Dis; 2021 Mar; 104():34-40. PubMed ID: 33359949
[TBL] [Abstract][Full Text] [Related]
33. Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus.
Morita S; Takahashi T; Yoshida Y; Yokota N
Ther Drug Monit; 2016 Apr; 38(2):259-67. PubMed ID: 26587870
[TBL] [Abstract][Full Text] [Related]
34. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.
Infante M; Ricordi C; Alejandro R; Caprio M; Fabbri A
Expert Rev Anti Infect Ther; 2021 Jan; 19(1):5-16. PubMed ID: 32693652
[TBL] [Abstract][Full Text] [Related]
35. Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study.
Saib A; Amara W; Wang P; Cattan S; Dellal A; Regaieg K; Nahon S; Nallet O; Nguyen LS
PLoS One; 2021; 16(6):e0252388. PubMed ID: 34106964
[TBL] [Abstract][Full Text] [Related]
36. Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
Jung SY; Kim MS; Kim MC; Choi SH; Chung JW; Choi ST
Clin Microbiol Infect; 2021 Apr; 27(4):611-617. PubMed ID: 33316402
[TBL] [Abstract][Full Text] [Related]
37. Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings.
Gasperetti A; Biffi M; Duru F; Schiavone M; Ziacchi M; Mitacchione G; Lavalle C; Saguner A; Lanfranchi A; Casalini G; Tocci M; Fabbricatore D; Salghetti F; Mariani MV; Busana M; Bellia A; Cogliati CB; Viale P; Antinori S; Galli M; Galiè N; Tondo C; Forleo GB
Europace; 2020 Dec; 22(12):1855-1863. PubMed ID: 32971536
[TBL] [Abstract][Full Text] [Related]
38. Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.
Kamalov AA; Mareev VY; Orlova YA; Plisyk AG; Akopyan ZA; Mareev YV; Mershina EA; Begrambekova YL; Pakhomov PV
Kardiologiia; 2021 Mar; 61(2):28-39. PubMed ID: 33734044
[TBL] [Abstract][Full Text] [Related]
39. Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
Özdemir İH; Özlek B; Özen MB; Gündüz R; Çetin N; Bilge AR
Int J Clin Pract; 2021 Feb; 75(2):e13896. PubMed ID: 33280207
[TBL] [Abstract][Full Text] [Related]
40. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
